KP 103

Known as: KP-103, KP103 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2014
0119992014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
BACKGROUND Topical therapies for onychomycosis are associated with less adverse events than systemic therapies, but poor nail… (More)
Is this relevant?
2002
2002
The therapeutic efficacy of KP-103, a novel topical triazole, in a guinea pig tinea unguium model was investigated. Experimental… (More)
Is this relevant?
2002
2002
The therapeutic efficacy of KP-103, a triazole derivative, for 10 guinea pigs with interdigital tinea pedis or tinea corporis was… (More)
Is this relevant?
2002
2002
We developed a new technique for culture study that successfully recovers fungi from drug-treated skin tissues, in which tissue… (More)
Is this relevant?
2001
2001
The in vitro activity of KP-103, a novel triazole derivative, against pathogenic fungi that cause dermatomycoses and its… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1999
1999
2-Aryl-1-azolyl-3-(substituted amino)-2-butanol derivatives I were prepared by ring-opening reaction of epoxides II with excess… (More)
  • table 1
  • table 1
  • table 2
  • figure 1
Is this relevant?